“A prospective study to monitor the side effects associated with disease modifying anti rheumatoid drugs in out-patients of tertiary care hospital” (2023) International Journal of Research in Pharmacology & Pharmacotherapeutics, 12(1), pp. 1–7. doi:10.61096/ijrpp.v12.iss1.2023.1-7.